Sapientia Pharmaceuticals' Acquisition

Sapientia Pharmaceuticals was acquired by BriaCell Therapeutics on July 24, 2017.

Sapientia Pharmaceuticals is a biotechnology company that is developing novel targeted therapeutics for multiple indications including several cancers and fibrotic diseases.…

Articles about Sapientia Pharmaceuticals' Acquisition: